Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100-mg in treatment-naïve HIV-infected patients

S. Lambert-Niclot*, N. Machouf, G. Peytavin, C. Soulie, M. Wirden, A. Simon, R. L. Murphy, C. Katlama, R. Thomas, V. Calvez, A. G. Marcelin

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'Pharmacokinetics, protein-binding-adjusted inhibitory quotients for atazanavir/ritonavir 300/100-mg in treatment-naïve HIV-infected patients'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science